Prevention of post-thrombotic syndrome: a case for new oral anticoagulant drugs or for heparins?

Link to article at PubMed

Prevention of post-thrombotic syndrome: a case for new oral anticoagulant drugs or for heparins?

J Thromb Haemost. 2012 Jun 5;

Authors: Baglin T

Abstract
Oral Direct Inhibitors (ODIs) of thrombin and factor Xa have now been shown to be at least as effective as warfarin in preventing recurrence of deep vein thrombosis (DVT). It is not yet known if there is a benefit of treatment with ODIs on reduction of incidence and severity of post-thrombotic syndrome (PTS). However, there is good reason to believe there might be and that the potential benefit would translate into a major reduction of disease burden. © 2012 International Society on Thrombosis and Haemostasis.

PMID: 22672412 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *